European League Against Rheumatism

European League Against Rheumatism

Open Access statistics for European League Against Rheumatism, Switzerland, covering academic research published from 2001 to 2023.

Open Access statistics for European League Against Rheumatism, Switzerland, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

78%


Total
Publications

249


Total Open
Publications

194


Total
Citations

29K


Open Access
Percentage

78%


Total
Publications

249


Total Open
Publications

194


Total
Citations

29K

Website

download

Breakdown

31% 38% 9% 22%

Publisher Open

31%

Both

38%

Other Platform Open

9%

Closed

22%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

40

Hybrid 20%

35

No Guarantees 57%

98

Other Platform Open

Institution 78%

91

Domain 60%

70

Other Internet 21%

24

Preprint 3%

4

Public 3%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
71
University of Leeds, The University of Sheffield, University of York - White Rose Research Online
Institution
30
Europe PMC
Domain
30
University College London - UCL Discovery
Institution
27
University of Oxford - Oxford Academic Notes & Queries
Institution
18
The University of Manchester - Research Explorer
Institution
16
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
16
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
15
The University of Glasgow - Enlighten: Publications
Institution
13
whiterose.ac.uk OAI-PMH Repository
Institution
11
1 / 9

Data updated 8 December 2024

Share

Share

Share